Aristeia Capital’s Baird Medical Investment Holdings Warrant BDMDW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$26.5K Hold
570,992
– – ﹤0.01% 727
2026
Q1
$60K Hold
570,992
– – ﹤0.01% 568
2025
Q4
$31.7K Hold
570,992
– – ﹤0.01% 539
2025
Q3
$40.7K Hold
570,992
– – ﹤0.01% 464
2025
Q2
$46.4K Buy
570,992
+100,000
+21% +$6.97K ﹤0.01% 422
2025
Q1
$42.3K Buy
470,992
+241,585
+105% +$25.1K ﹤0.01% 367
2024
Q4
$56.3K Buy
+229,407
New +$9.09K ﹤0.01% 309

Other funds holding BDMDW

Aristeia Capital's BDMDW Position: Q2 2026 in Review

Aristeia Capital held its Baird Medical Investment Holdings Warrant (BDMDW) position steady in Q2 2026 at 570,992 shares worth $26.5K. The position accounts for ﹤0.01% of the portfolio, ranked #727.

Aristeia Capital first reported a position in BDMDW in Q4 2024 and has held it in 7 quarters since. The position peaked at $60K in Q1 2026. 29 funds tracked by Wall St. Rank hold BDMDW as of Q2 2026.

  • Aristeia Capital held 570,992 shares of Baird Medical Investment Holdings Warrant worth $26.5K as of Q2 2026.
  • Aristeia Capital left its Baird Medical Investment Holdings Warrant share count unchanged in Q2 2026.
  • Baird Medical Investment Holdings Warrant made up ﹤0.01% of Aristeia Capital's portfolio in Q2 2026, its #727 holding.
  • Aristeia Capital first reported a position in Baird Medical Investment Holdings Warrant in Q4 2024 and has held it in 7 quarters since.
  • Aristeia Capital's Baird Medical Investment Holdings Warrant position peaked at $60K in Q1 2026.
  • 29 funds tracked by Wall St. Rank held Baird Medical Investment Holdings Warrant as of Q2 2026.

Based on Aristeia Capital's 13F filing for Q2 2026, filed 14 Aug 2026.